Abstract
This review addresses the use of chemical analyses to validate the smoking status of a participant in a smoking cessation program. Phamacokinetic and chemical validation literature leads to the conclusion that chemical analyses are most reliably used to confirm abstinence from smoking rather than as quantitative measures of nicotine intake or smoking activity. Analytical methodologies used in smoking validation studies are reviewed with their advantages and disadvantages. Close collaboration of behavioral scientists and analytical chemists is encouraged to validate the smoking status of participants in a smoking cessation program.
Similar content being viewed by others
References
Abrams, D. B., Follick, M. J., Biener, L., Carey, K. B., and Hitti, J. (1987). Saliva cotinine as a measure of smoking status in field sellings.Am. J. Public Health 77: 846–848.
Barlow, R. D., Stone, R. B., Wald, N. J., and Puhakainen, E. V. J. (1987a). The direct barbituric acid assay for nicotine metabolites in urine: A simple colorimetric test for the routine assessment of smoking status and cigarette smoke intake.Clin. Chim. Acta 165: 45–52.
Barlow, R. D., Thompson, P. A., and Stone, R. B. (1987b). Simultaneous determination of nicotine, cotinine and five additional nicotine metabolites in the urine of smokers using pre-column derivatisation and high-performance liquid chromatography.J. Chromatogr. 419: 375–380.
Benkirane, S., Nicholas, A., Galteau, M.-M., and Siest, G. (1991). Highly sensitive immuno-assays for the determination of cotinine in serum and saliva. Comparison between RIA and an Avidin-biotin ELISA.Eur. J. Clin. Chem. Clin. Biochem. 29: 405–410.
Benowitz, N. L., and Jacob, P., III (1984). Daily intake of nicotine during cigarette smoking.Clin. Pharmacol. Ther. 35: 499–504.
Benowitz, N. L., Jacob, P., III, Jones, R. T., and Rosenberg, J. (1982). Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.J. Pharmacol. Exp. Ther. 221: 368–372.
Benowitz, N. L., Kuyt, F., Jacob, P., III, Jones, R. T., and Osman, A. L. (1983). Cotinine disposition and effects.Clin. Pharmacol. Ther. 34: 604–611.
Benowitz, N. L., Porchet, H., and Jacob, P., III (1990). Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In Wonnacott, S., Russell, M. A. H., and Stolerman, I. P. (eds.),Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects, Oxford University Press, New York, pp. 112–157.
Boltz, D. F., and Howell, J. A. (eds.) (1978). In Elving, P. J., Winefordner, J. D., and Kolthoff, I. M. (eds.),Colorimetric Determination of Nonmetals, 2nd ed., Chemical Analysis, Vol. 8, John Wiley & Sons, New York, pp. 79–80.
Bridges, R. B., Combs, J. G., Humble, J. W., Turbek, J. A., Rehm, S. R., and Haley, N. J. (1990a). Population characteristics and cigarette yield as determinants of smoke exposure.Pharmacol. Biochem. Behav. 37: 17–28.
Bridges, R. B., Combs, J. G., Humble, J. W., Turbek, J. A., Rehm, S. R., and Haley, N. J. (1990b). Puffing topology as a determinant of smoke exposure.Pharmacol. Biochem. Behav. 37: 29–39.
Butts, W. C., Kuehneman, M., and Widdowson, G. M. (1974). Automated method for determining serum thiocyanate, to distinguish smokers from nonsmokers.Clin. Chem. 20: 1344–1348.
Cole, P. (1981). Smoking habits and carbon monoxide. In Greenhalg, R. M., (ed.),Smoking and Arterial Disease, Pitman Press, Bath, UK, pp. 74–83.
Cummings, S. R., and Richard, R. J. (1988). Optimum cutoff points for biochemical validation of smoking status.Am. J. Public Health 78: 574–575.
Curvall, M., Kazemi-Vala, E., and Enzell, C. R. (1982). Simultaneous determination of nicotine and cotinine in plasma using capillary column gas chromatography with nitrogen-sensitive detection.J. Chromatogr. 232: 283–293.
Curvall, M., Elwin, C.-E., Kazemi-Vala, E., Warholm, C., and Enzell, C. R. (1990). The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers.Eur. J. Clin. Pharmacol. 38: 281–287.
Danhof, M., and Breimer, D. D. (1978). Therapeutic drug monitoring in saliva.Clin. Pharmacokinet. 3: 39–57.
Densen, P. M., Davidow, B., Bass, H. E., and Jones, E. W. (1967). A chemical test for smoking exposure.Arch. Environ. Health 14: 865–874.
Etzel, R. A. (1990). A review of the use of saliva cotinine as a marker of tobacco smoke exposure.Prev. Med. 19: 190–197.
Feyerabend, C., and Russell, M. A. H. (1990). A rapid gas-liquid Chromatographic method for the determination of cotinine and nicotine in biological fluids.J. Pharm. Pharmacol. 42: 450–452.
Feyerabend, C., Ings, R. M. J., and Russell, M. A. H. (1985). Nicotine pharmacokinetics and its application to intake from smoking.Br. J. Clin. Pharmacol. 19: 239–247.
Feyerabend, C., Bryant, A. E., Jarvis, M. J., and Russell, M. A. H. (1986). Determination of cotinine in biological fluids of non-smokers by packed column gas-liquid chromatography.J. Pharm. Phamacol. 38: 917–919.
Galeazzi, R. L., Daenens, P., and Gugger, M. (1985). Steady-state concentrations of cotinine as a measure of nicotine-intake by smokers.Eur. J. Clin. Pharmacol. 28: 301–304.
Godin, J., and Hellier, G. (1989). Method for the determination of nicotine and cotinine in urine by high-performance liquid chromatography.J. Chromatogr. 488: 487–491.
Herning, R. I., Jones, R. T., Benowitz, N. L., and Mines, A. H. (1983). How a cigarette is smoked determines blood nicotine levels.Clin. Pharmacol. Ther. 33: 84–90.
Jacob, P., III, Wilson, M., and Benowitz, N. L. (1981). Improved gas Chromatographic method for the determination of nicotine and cotinine in biological fluids.J. Chromatogr. 222: 61–70.
Jacob, P., III, Benowitz, N. L., and Shulgin, A. T. (1988). Recent studies of nicotine metabolism in humans.Pharmacol. Biochem. Behav. 30: 249–253.
Jarvis, M. J., Russell, M. A. H., Feyerabend, C., Eiser, J. R., Morgan, M., Gammage, P., and Gray, E. M. (1985). Passive exposure to tobacco smoke: Saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren.Br. Med. J. 291: 927–929.
Jarvis, M. J., Belcher, M., Vesey, C., and Hutchison, D. C. S. (1986). Low cost carbon monoxide monitors in smoking assessment.Thorax 41: 886–887.
Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., and Saloojee, Y. (1987). Comparison of tests used to distinguish smokers from nonsmokers.Am. J. Public Health 77: 1435–1438.
Jarvis, M. J., Russell, M. A. H., Benowitz, N. L., and Feyerabend, C. (1988). Elimination of cotinine from body fluids: Implications for noninvasive measurement of tobacco smoke exposure.Am. J. Public Health 78: 696–698.
Kyerematen, G. A., Morgan, M. L., Chattopadhyay, B., and deBethizy, J. D. (1990). Disposition of nicotine and eight metabolites in smokers and nonsmokers: Identification in smokers of two metabolites that are longer lived than cotinine.Clin. Pharmacol. Ther. 48: 641–651.
Langone, J. J., Gjika, H. B., and Van Vunakis, H. (1973). Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine.Biochemistry 12: 5025–5030.
Langone, J. J., Cook, G., Bjerke, R. J., and Lifschitz, M. H. (1988). Monoclonal antibody ELISA for cotinine in saliva and urine of active and passive smokers.J. Immunol. Methods 114: 73–78.
Luepker, R. V., Pechacek, T. F., Murray, D. M., Johnson, C. A., Hund, F., and Jacobs, D. R. (1981). Saliva thiocyanate: A chemical indicator of cigarette smoking in adolescents.Am. J. Public Health 71: 1320–1324.
Lundquist, P., Martensson, J., Sorbo, B., and Ohman, S. (1979). Method for determining thiocyanate in serum and urine.Clin. Chem. 25: 678–681.
Machacek, D. A., and Jiang, N. S. (1986). Quantification of cotinine in plasma and saliva by liquid chromatography.Clin. Chem. 32: 979–982.
McNeill, A. D., Owen, L. A., Belcher, M., Sutherland, G., and Fleming, S. (1990). Abstinence from smoking and expired air-carbon monoxide levels: Lactose intolerance as a possible source of error.Am. J. Public Health 80: 1114–1115.
Mulligan, S. C., Masterton, J. G., Devane, J. G., and Kelly, J. G. (1990). Clinical and pharmacokinetic properties of a transdermal nicotine patch.Clin. Pharmacol. Ther. 47: 331–337.
Noland, M. P., Kryscio, R. J., Riggs, R. S., Linville, L. H., Perritt, L. J., and Tucker, T. C. (1988). Saliva cotinine and thiocyanate: Chemical indicators of smokeless tobacco and cigarette use in adolescents.J. Behav. Med. 11: 423–433.
O'Doherty, S., Cooke, M., and Roberts, D. J. (1990). Enhancing the LC analysis of nicotine and its metabolites in urine using Meldrurm's acid as a complexing agent.J. High Resolut. Chromatogr. 13: 74–77.
Onishi, H. (1986). In Elving, P. J., Winefordner, J. D., and Kolthoff, I. M. (eds.),Photometric Determination of Traces of Metals, Chemical Analysis, Vol. 3, pt. IIA, 4th ed., John Wiley & Sons, New York, pp. 713–724.
Orleans, C. S., and Shipley, R. H. (1982). Assessment in smoking cessation research. In Keefe, F. J., and Blumenthal, J. A. (eds.),Assessment Strategies in Behavioral Medicine, Grune & Stratton, New York, pp. 261–320.
Parviainen, M. T., and Barlow, R. D. (1988). Assessment of exposure to environmental tobacco smoke using a high-performance liquid Chromatographic method for the simultaneous determination of nicotine and two of its metabolites in urine.J. Chromatogr. 431: 216–221.
Peach, H., Ellard, G. A., and Morris, R. W. (1985). A simple, inexpensive urine test of smoking.Thorax 40: 351–357.
Pechacek, T. F., Fox, B. H., Murray, D. M., and Leupker, R. V. (1984). Review of techniques for measurement of smoking behavior. In Matarazzaro, J. D., Herd, J. A., Miller, N. E., and Weiss, S. M. (eds.),Behavioral Health: A Handbook of Health Enhancement and Disease Prevention, J. Wiley & Sons, New York, pp. 729–754.
Pettigrew, A. R., and Fell, G. S. (1972). Simplified colorimetric determination of thiocyanate in biological fluids and its application to investigation of the toxic amblypopias.Clin. Chem. 18: 996–1000.
Pichini, S., Altieri, I., Pacifici, R., Rosa, M., and Zuccaro, P. (1991). Elimination of caffeine interference in high-performance liquid Chromatographic determination of cotinine in human plasma.J. Chromatogr. 568: 267–269.
Pierce, J. P., Dwyer, T., DiGiusto, E., Carpenter, T., Hannam, C., Amin, A., Yong, C., Sarfaty, G., Shaw, J., and Burke, S. N. (1987). Cotinine validation of self-reported smoking in commercially run community surveys.J. Chron. Dis. 40: 689–695.
Pojer, R., Whitfield, J. B., Poulos, V., Eckhard, I. F., Richmond, R., and Hensley, W. J. (1984). Carboxyhemoglobin, cotinine, and thiocyanate assay compared for distinguishing smokers from non-smokers.Clin. Chem. 30: 1377–1380.
Proctor, C. J., Warren, N. G., Bevan, M. A. J., and Baker-Rogers, J. (1991). A comparison of methods of assessing exposure to environmental tobacco smoke in non-smoking British women.Environ. Int. 17: 287–297.
Puhakainen, E. V. J., Barlow, R. D., and Salonen, J. T. (1987). An automated colorimetric assay for urine nicotine metabolites: A suitable alternative to cotinine assays for the assessment of smoking status.Clin. Chim. Acta 170: 255–262.
Russell, M. A. H., Jarvis, M. J., Devitt, G., and Feyerabend, C. (1981). Nicotine intake by snuff users.Br. Med. J. 283: 814–817.
Russell, M. A. H. (1990). Nicotine intake and its control over smoking. In Wonnacott, S., Russell, M. A. H., and Stolerman, I. P. (eds.),Nicotine Psychopharmacology: Molecular Cellular, and Behavioural Aspects, Oxford University Press, New York, pp. 374–418.
Schepers, G., and Walk, R.-A. (1988). Cotinine determination by immunoassays may be influenced by other nicotine metabolites.Arch. Toxicol. 62: 395–397.
Schievelbein, H., Heinemann, G., Loschenkohl, K., Troll, C., and Schlegel, J. (1978). Metabolie aspects of smoking behavior. In Thorton, R. E. (ed.),Smoking Behavior: Physiological and Psychological Influences, Livingstone, Edinburgh, Scotland, pp. 371–379.
Smith, C. L., O'Doherty, S., Cooke, M., and Roberts, D. J. (1989). Determination of nicotine metabolites by HPLC after complexation with diethylthiobarbituric acid.Anal. Proc. (London) 26: 348–351.
Sonnenworth, A. C., and Jarrett, L. (eds.) (1980).Gradwohl's Clinical Laboratory Methods and Diagnosis, 8th ed., Mosby, St. Louis, pp. 814–815.
Turner, J. A. McM., Ball, K. P., and Sillett, R. W. (1981). Deception among cigarette smokers. In Greenhalgh, R. M. (ed.),Smoking and Arterial Disease, Pitman Press, Bath, UK, pp. 60–63.
U.S. Department of Health and Human Services (1990). Assessing smoking cessation and its health consequences. InThe Health Benefits of Smoking Cessation. A Report of the Surgeon General, DHHS Publication No. (CDC) 90-8416, pp. 17–69.
Vesey, C. J. (1981). Thiocyanate and cigarette consumption. In Greenhalgh, R. M. (ed.),Smoking and Arterial Disease, Pitman Press, Bath, UK, pp. 106–121.
Wagenknecht, L. E., Cutter, G. R., Haley, N. J., Sidney, S., Manolio, T. A., Hughes, G. H., and Jacobs, D. R. (1990). Racial differences in serum cotinine levels among smokers in the coronary artery risk development in (young) adults study.Am. J. Public Health 80: 1053–1056.
Wagenknecht, L. E., Burke, G. L., Perkins, L. L., Haley, N. J., and Friedman, G. D. (1992). Misclassification of smoking status in the CARDIA study: A comparison of self-report with serum cotinine levels.Am. J. Public Health 82: 33–36.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilbert, D.D. Chemical analyses as validators in smoking cessation programs. J Behav Med 16, 295–308 (1993). https://doi.org/10.1007/BF00844761
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00844761